Oscar Health lifts 2026 revenue and earnings outlook after strong Q3 results
Oscar Health reported third‑quarter 2026 revenue of $5.1 billion, a 70% year‑over‑year increase, and net income of $167.3 million, reversing a loss from the prior year. Membership rose 27% to 2.7 million, while the medical loss ratio improved to 84.0% and the SG&A expense ratio fell to a record low of 14.0%. The company raised its full‑year 2026 guidance to $19.0‑$19.3 billion in revenue and $850‑$950 million in earnings from operations.
Why it matters
The higher guidance signals stronger profitability and cash generation, which could support a higher valuation for OSCR shares. The raised outlook also reflects successful cost management and market expansion, reducing downside risk for investors.
Key facts
- 1Q3 2026 total revenue was $5.1 billion, up 70% YoY. fool.com
- 2Membership reached 2.7 million, a 27% YoY increase. fool.com
- 3Net income was $167.3 million, or $0.49 per diluted share. fool.com
- 4Medical loss ratio improved to 84.0%, a 450‑basis‑point gain YoY. fool.com
- 5SG&A expense ratio fell to 14.0%, a 350‑basis‑point decline YoY. fool.com
- 6Earnings from operations were $178 million, $307 million higher than the prior year. fool.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.